All Insights
Showing 109 - 120 of 240
COP27
COP26 | Energy Day
Welcome to the fourth instalment of our daily COP26 updates: a digest of what is on the agenda each day
Sustainable disruption: 12 decarbonising technologies for cities
Can sustainable disruption and technology deliver decarbonised cities?
Against the backdrop of COP26, the reduction of carbon emissions in cities and identifying methodology, technology and investment to achieve
COP27
COP26 | World Leaders' Summit begins
Welcome to the first instalment of our daily COP26 updates: a digest of what is on the agenda each day
Life Sciences and Healthcare
EUIPO trade mark decision makes protection for medical devices harder to achieve
Boehringer's EU shape trade mark for its HandiHaler declared invalid for performing a technical function
Sustainable disruption: 12 decarbonising technologies for cities
Sustainable disruption: 12 decarbonising technologies for cities
New research by Economist Impact , supported by Osborne Clarke, has identified 12 technologies that can help cities achieve their
Life Sciences and Healthcare
UK sets out plans to diverge from EU regime on gene editing in plants
The government has signalled its intention to pave the way for gene-edited crops following a consultation on departing from EU
Life Sciences and Healthcare
The government has vision for the UK as the world's leading hub for life sciences
Details on the funding of the 10-year strategy, which builds on the UK's world-class capability and on lessons from the
Hemp tea - the fine line between food and narcotics
The first article from our series "Cannabis - the 'green gold' from a legal perspective"
Life Sciences and Healthcare
Debate intensifies over a vaccine IP waiver's impact on future pharma and biotech discoveries
Does a proposed patent suspension backed by Washington open a Pandora's box for vaccine R&D and investment?
Life Sciences and Healthcare
Queen's Speech 2021 sets out ambitious agenda for UK life sciences and healthcare
New parliamentary term will be packed with legislation for life sciences and healthcare businesses
Life Sciences and Healthcare
Patents Court upholds validity of second medical use patent for glaucoma treatment
This decision shows the court assessing patentability in a real-world practical context, recognising the uncertainties of R&D that only later